Privileged 1,2,4-Oxadiazoles in Anticancer Drug Design: Novel 5- Aryloxymethyl-1,2,4-oxadiazole Leads for Prostate Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|3|198-204

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.3, 2016-03, pp. : 198-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1,2,4-Oxadiazole as a Privileged Scaffold for Anti-inflammatory and Analgesic Activities: A Review

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 18, 2018-11 ,pp. : 1536-1547

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis, Crystal Structure, and Antimicrobial Evaluation of Novel Pyrazolyl-1,3,5-oxadiazoles, Pyrazolyl-1,2,4-triazoles and their Related Thioglycosides

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 5, 2013-06 ,pp. : 444-452

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of 1,2,4-oxadiazoles (a review)

By Kayukova L.  

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 10, 2005-10 ,pp. : 539-547

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and Cytotoxicity Evaluation of Some Novel 3,5-disubstituted- 1,2,4-Oxadiazoles

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 10, 2012-01 ,pp. : 942-946

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Antimicrobial Activity of Substituted Nitro-1,2,4-oxadiazole-5-carbaldehyde Hydrazones

By Tyrkov A. G.   Sukhenko L. T.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 7, 2004-07 ,pp. : 376-378

Springer Publishing Company

Access to resources Recommend Favorite